Literature DB >> 15468376

Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus.

Chiang-Hua Liao1, Tsung-Chieh Yao, Hung-Tao Chung, Lai-Chu See, Ming-Ling Kuo, Jing-Long Huang.   

Abstract

OBJECTIVE: Chemokines play an important role in the physiology and pathophysiology of acute and chronic inflammatory processes. We investigated whether chemokines such as RANTES (regulated upon activation, normally T cell expressed and secreted) promoter and monocyte chemoattractant protein-1 (MCP-1) regulatory polymorphisms were associated with systemic lupus erythematosus (SLE) in Chinese children.
METHODS: Forty-six patients with SLE and 107 healthy children of comparable ages were studied for genotypes with polymerase chain reaction-based assays.
RESULTS: The frequency and distribution of genotypes of the -28(C/G) RANTES gene polymorphism were significantly different between the 2 groups (p < 0.001), and the RANTES -28G allele was significantly more frequent in patients with SLE than in healthy controls (23.9% vs 11%; p = 0.006, OR 2.37, 95% CI 1.25-4.28). There was no significant difference in the frequency or in the distribution of genotypes of the -2518(A/G) MCP-1 and the -403(G/A) RANTES gene polymorphisms between patients and controls (p = 0.32 and p = 0.19, respectively). The RANTES -28G allele was also significantly associated with higher initial levels of antinuclear antibody, lower levels of C3, and higher incidences of central nervous system lupus.
CONCLUSION: In the Chinese population, children with RANTES -28C/G polymorphisms have increased risk of developing SLE. Healthy controls with the C/G or G/G genotype were 2.37 times more likely to have SLE compared to those with the C/C genotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15468376

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

Review 1.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

2.  Association of MCP-1-2518A/G polymorphism with susceptibility to autoimmune diseases: a meta-analysis.

Authors:  Si Chen; Chuiwen Deng; Chaojun Hu; Jing Li; Xiaoting Wen; Ziyan Wu; Yuan Li; Fengchun Zhang; Yongzhe Li
Journal:  Clin Rheumatol       Date:  2015-08-29       Impact factor: 2.980

3.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 4.  Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Authors:  Yi Li; Pui Y Lee; Westley H Reeves
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-07-31       Impact factor: 4.291

5.  Meta-analysis of MCP-1 promoter -2518 A/G polymorphism and SLE susceptibility.

Authors:  Ting Liu; Jin-Xia Zhai; Han-Yong Wang; Xing-Hua Wang; Li-Wei Zou; Wen-Jing Fan; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2012-06-17       Impact factor: 2.316

6.  Association of RANTES and MBL gene polymorphisms with systemic lupus erythematosus: a meta-analysis.

Authors:  Wang-Dong Xu; Hui Peng; Mo Zhou; Min Zhang; Bao-Zhu Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

7.  Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism might be associated with renal disease and thrombocytopenia of SLE.

Authors:  Piotr Piotrowski; Margarita Lianeri; Robert Gasik; Andrzej Roszak; Marzena Olesińska; Paweł P Jagodziński
Journal:  J Biomed Biotechnol       Date:  2010-04-21

8.  Functional monocyte chemoattractant protein-1 promoter -2518 polymorphism and systemic lupus erythematosus: a meta-analysis.

Authors:  Young Ho Lee; Jin-Hyun Woo; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2009-11-26       Impact factor: 2.316

Review 9.  CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.

Authors:  Dandan Lv; Yan Zhang; Ha-Jeong Kim; Lixing Zhang; Xiaojing Ma
Journal:  Cell Mol Immunol       Date:  2013-02-04       Impact factor: 11.530

10.  Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis.

Authors:  Muhammad A Ahad; Tom Missotten; Atiyeh Abdallah; Penny A Lympany; Susan Lightman
Journal:  Mol Vis       Date:  2007-03-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.